000141292 001__ 141292
000141292 005__ 20240229105123.0
000141292 0247_ $$2doi$$a10.1038/s41395-018-0209-2
000141292 0247_ $$2pmid$$apmid:30315282
000141292 0247_ $$2ISSN$$a0002-9270
000141292 0247_ $$2ISSN$$a1572-0241
000141292 037__ $$aDKFZ-2018-01812
000141292 041__ $$aeng
000141292 082__ $$a610
000141292 1001_ $$0P:(DE-He78)415ba72b9b033eb7eeb48292f498cced$$aPeng, Le$$b0$$eFirst author$$udkfz
000141292 245__ $$aRisk Scores for Predicting Advanced Colorectal Neoplasia in the Average-risk Population: A Systematic Review and Meta-analysis.
000141292 260__ $$aLondon [u.a.]$$bNature$$c2018
000141292 3367_ $$2DRIVER$$aarticle
000141292 3367_ $$2DataCite$$aOutput Types/Journal article
000141292 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1579773144_10557$$xReview Article
000141292 3367_ $$2BibTeX$$aARTICLE
000141292 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000141292 3367_ $$00$$2EndNote$$aJournal Article
000141292 500__ $$a2018 Dec;113(12):1788-1800
000141292 520__ $$aA systematic review and meta-analysis was performed to summarize the available evidence on risk scores for predicting advanced colorectal neoplasia (advanced adenomas and cancer) in average-risk and asymptomatic populations undergoing screening colonoscopy.PubMed, EMBASE, and Web of Science databases were searched up to 28 March 2018. Studies that developed or validated a risk score to predict the risk of advanced colorectal neoplasia were included. Two reviewers independently extracted study characteristics including diagnostic performance indicators and assessed risk of bias and applicability in the included studies. Meta-analyses were conducted to determine the overall discrimination of risk scores evaluated by more than 1 study.A total of 22 studies including 17 original risk scores were identified. Risk scores included a median number of 5 risk factors. Factors most commonly included were age, sex, family history in first-degree relatives, body mass index and smoking. The area under the receiver operating characteristic curve of risk scores ranged from 0.62 to 0.77 in the individual studies and from 0.61 to 0.70 in the meta-analyses.Although the majority of available risk scores had relatively weak discriminatory power, they may be of some use for risk stratification in CRC screening. Rather than developing more risk scores based on environmental risk factors, future research should focus on exploring possibilities of enhancing predictive power by combining risk factor data with novel laboratory matters, such as polygenetic risk scores.
000141292 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000141292 588__ $$aDataset connected to CrossRef, PubMed,
000141292 7001_ $$0P:(DE-He78)f4e98340e600f7411886c21c7b778d36$$aWeigl, Korbinian$$b1$$udkfz
000141292 7001_ $$0P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aBoakye, Daniel$$b2$$udkfz
000141292 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b3$$eLast author$$udkfz
000141292 773__ $$0PERI:(DE-600)2003227-4$$a10.1038/s41395-018-0209-2$$n12$$p1788-1800$$tThe American journal of gastroenterology$$v113$$x1572-0241$$y2018
000141292 909CO $$ooai:inrepo02.dkfz.de:141292$$pVDB
000141292 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)415ba72b9b033eb7eeb48292f498cced$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000141292 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f4e98340e600f7411886c21c7b778d36$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000141292 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)657300dfd28903ec8149ca9bf5e7968d$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000141292 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000141292 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000141292 9141_ $$y2018
000141292 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J GASTROENTEROL : 2017
000141292 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000141292 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000141292 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000141292 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000141292 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000141292 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000141292 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000141292 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000141292 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000141292 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000141292 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000141292 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bAM J GASTROENTEROL : 2017
000141292 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lKlinische Epidemiologie und Alternsforschung$$x0
000141292 9201_ $$0I:(DE-He78)G110-20160331$$kG110$$lPräventive Onkologie$$x1
000141292 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x2
000141292 980__ $$ajournal
000141292 980__ $$aVDB
000141292 980__ $$aI:(DE-He78)C070-20160331
000141292 980__ $$aI:(DE-He78)G110-20160331
000141292 980__ $$aI:(DE-He78)L101-20160331
000141292 980__ $$aUNRESTRICTED